Varaico: Literature-Extracted Genetic Variants

Gene:CPT2
Variant:p.F448L
Back to variants list

CPT2

NM_000098.3:p.F448L

Associated Papers

Recurrent rhabdomyolysis caused by palmitoyltransferase II (CPT-2) deficiency but complete normal acylcarnitine profile: A patient presentation and review of the literature.

Lu CH et al.

Molecular Genetics and Metabolism Reports, 2024

A case study of lethal neonatal CPT II deficiency: Novel insights from genetic analysis.

Tran TCM et al.

Molecular Genetics and Metabolism Reports, 2024

Carnitine Palmitoyltransferase II (CPT2) Deficiency: An Overlooked and Elusive Cause of Acute Kidney Injury.

Seferi S et al.

Cureus, 2024

Carnitine palmitoyltransferase II (CPT II) deficiency responsible for refractory cardiac arrhythmias, acute multiorgan failure and early fatal outcome.

Serra G et al.

Italian Journal of Pediatrics, 2024

Reanalysis of Trio Whole-Genome Sequencing Data Doubles the Yield in Autism Spectrum Disorder: De Novo Variants Present in Half.

Bar O et al.

International Journal of Molecular Sciences, 2024

38256266 (PubMed )
Supplement: ijms-25-01192-s001.zip › ijms-2816629-supplementary.xlsx › Table_S2

The role of genetic defects in carnitine-associated hepatic encephalopathy: a review of literature.

Kheirandish A et al.

Gastroenterology and Hepatology From Bed to Bench, 2024

Myopathic Carnitine Palmitoyltransferase II (CPT II) Deficiency: A Rare Cause of Acute Kidney Injury and Cardiomyopathy.

Castillo E et al.

Cureus, 2023

Assessment of the Diagnostic Yield of Combined Cardiomyopathy and Arrhythmia Genetic Testing.

Dellefave-Castillo LM et al.

Jama Cardiology, 2022

35947370 (PubMed )
Supplement: jamacardiol-e222455-s002.xlsx › Supplemental_Table3_rollup

Infantile onset carnitine palmitoyltransferase 2 deficiency: Cortical polymicrogyria, schizencephaly, and gray matter heterotopias in an adolescent with normal development.

Shelihan I et al.

Jimd Reports, 2022

35028265 (PubMed )
Supplement: JMD2-63-3-s001.pdf

A rare presentation of Carnitine palmitoyltransferase II (CPT-2) deficiency with normal acylcarnitine profile in a 10-year-old boy with muscle weakness and bilateral hearing loss; a case report.

Vafaee Shahi M et al.

Iranian Journal of Child Neurology, 2022

Muscle Carnitine Palmitoyltransferase II (CPT II) Deficiency: A Conceptual Approach.

Joshi PR et al.

Molecules (basel, Switzerland), 2020

Lifetime risk of autosomal recessive mitochondrial disorders calculated from genetic databases.

Tan J et al.

Ebiomedicine, 2020

32305867 (PubMed )
Supplement: mmc3.xlsx › Excluded_variants

Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population.

Rivas MA et al.

Plos Genetics, 2018

Malignant Hyperthermia Susceptibility and Related Diseases.

Litman RS et al.

Anesthesiology, 2018

MitoFates: improved prediction of mitochondrial targeting sequences and their cleavage sites.

Fukasawa Y et al.

Molecular & Cellular Proteomics : Mcp, 2015

25670805 (PubMed )
Supplement: supp_M114.043083_mcp.M114.043083-16.xlsx › TableS9A

Carnitine palmitoyl transferase II deficiency in an adolescent presenting with rhabdomyolysis and acute renal failure.

Topçu Y et al.

Pediatric Emergency Care, 2014

Single nucleotide polymorphism in CPT1B and CPT2 genes and its association with blood carnitine levels in acute myocardial infarction patients.

Khan HA et al.

Gene, 2013

Mitochondrial fatty-acid oxidation disorders.

Kompare M et al.

Seminars in Pediatric Neurology, 2008

Autopsy case of the neonatal form of carnitine palmitoyltransferase-II deficiency triggered by a novel disease-causing mutation del1737C.

Semba S et al.

Pathology International, 2008

Muscle carnitine palmitoyltransferase II deficiency: clinical and molecular genetic features and diagnostic aspects.

Deschauer M et al.

Archives of Neurology, 2005

Carnitine palmitoyltransferase II deficiency: a clinical, biochemical, and molecular review.

Sigauke E et al.

Laboratory Investigation; a Journal of Technical Methods and Pathology, 2003

Correlation between genotype, metabolic data, and clinical presentation in carnitine palmitoyltransferase 2 (CPT2) deficiency.

Thuillier L et al.

Human Mutation, 2003

Carnitine palmitoyltransferase II deficiency: molecular and biochemical analysis of 32 patients.

Wieser T et al.

Neurology, 2003

Antenatal presentation of carnitine palmitoyltransferase II deficiency.

Elpeleg ON et al.

American Journal of Medical Genetics, 2001

Biochemical and molecular correlations in carnitine palmitoyltransferase II deficiency.

Vladutiu GD

Muscle & Nerve, 1999

Novel mutations associated with carnitine palmitoyltransferase II deficiency.

Taggart RT et al.

Human Mutation, 1999

[Carnitine palmitoyltransferase II(CPT2) deficiency].

Yorifuji S

Ryoikibetsu Shokogun Shirizu, 1998

Severe infantile carnitine palmitoyltransferase II deficiency in 19-week fetal sibs.

Meir K et al.

Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society, 0

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."